Chronically infused angiotensin II induces depressive-like behavior via microglia activation.

Sci Rep

Department of Pharmacology, Research Institute for Basic Medical Science, School of Medicine, CHA University, CHABIOCOMPLEX, 335 Pangyo, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea.

Published: December 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Brain inflammation is one of hypotheses explaining complex pathomechanisms of depression. Angiotensin II (ANGII), which is associated with hypertension, also induces brain inflammation. However, there is no animal study showing the direct relationship between ANGII and depression. To address this issue, ANGII-containing osmotic pumps were implanted into adult male C57BL/6 mice subcutaneously for subacute (7 days) and chronic (at least 21 days) periods and behavioral and molecular analyses were conducted. Chronic infusion of ANGII into mice induced depressive-like behaviors, including the tail suspension test and forced swimming test, which were reversed by imipramine. Chronic infusion of ANGII also induced microglial activation in the hippocampus with increase of Il-1β mRNA and decrease of Arg1 mRNA. In addition, chronic ANGII infusion activated the hypothalamic-pituitary-adrenal axis (HPA axis) and resulted in decreased hippocampal glucocorticoid receptor level. However, subacute ANGII infusion did not induce significant molecular and behavioral changes in mice compared to that of control. The molecular and behavioral changes by chronic ANGII infusion were reversed by co-treatment of minocycline or telmisartan. In addition, ANGII treatment also induced the pro-inflammatory changes in BV-2 microglial cells. Our results indicate that ANGII can induce depressive-like behaviors via microglial activation in the hippocampus and HPA axis hyperactivation in mice. These might suggest possible mechanism on depressive symptom in chronic hypertensive state.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744531PMC
http://dx.doi.org/10.1038/s41598-020-79096-2DOI Listing

Publication Analysis

Top Keywords

angii infusion
12
angii
9
brain inflammation
8
chronic infusion
8
infusion angii
8
depressive-like behaviors
8
microglial activation
8
activation hippocampus
8
chronic angii
8
hpa axis
8

Similar Publications

Cardiac hypertrophy is a common adaptation to cardiovascular stress and often a prelude to heart failure. We examined how S-palmitoylation of the small GTPase, Ras-related C3 botulinum toxin substrate 1 (Rac1), impacts cardiomyocyte stress signaling. Mutation of the cysteine-178 palmitoylation site impaired activation of Rac1 when overexpressed in cardiomyocytes.

View Article and Find Full Text PDF

Hypertension drives heterogeneous aortic remodeling, but the mechanisms underlying regional disparities remain unclear. Here, we demonstrate that adaptive immunity orchestrates spatial differences in vascular dysfunction by modulating perivascular adipose tissue (PVAT) phenotype and immune-metabolic crosstalk. Using angiotensin II (AngII)-infused wild-type (WT) and mice lacking T and B cells, we integrated biaxial mechanical testing, bulk transcriptomics, and PVAT analyses.

View Article and Find Full Text PDF

Introduction: QSOX1, a sulfhydryl oxidase involved in arterial remodelling, has recently emerged as a biomarker for preeclampsia and acute heart failure. This study sought the cardiovascular roles of Qsox1 in response to angiotensin II-induced hypertension.

Methods: With approval from an Animal Ethics Committee (CNREEA#9), two models were developed: Qsox1-invalidated adult male mice (Qsox1-/-) mice (C57BL/6J background) and a tamoxifen-inducible, vascular smooth muscle cells (VSMC)-specific Qsox1 knockout.

View Article and Find Full Text PDF

Microvascular Rarefaction in the Sinoatrial Node: A Potential Mechanism for Pacemaker Dysfunction in Early HFpEF.

JACC Clin Electrophysiol

July 2025

Departments of Physiology & Membrane Biology, School of Medicine, University of California-Davis, Davis, California, USA. Electronic address:

Background: Microvascular rarefaction is a feature of heart failure with preserved ejection fraction (HFpEF) that may underlie associated rhythm disturbances. Angiotensin II (AngII) signaling has been implicated, but its role in sinoatrial (SA) node dysfunction remains unclear.

Objectives: The authors tested whether changes in SA node microvascular architecture contribute to pacemaker dysfunction in early HFpEF.

View Article and Find Full Text PDF

Targeting N-Methyladenine of Tubular Mitochondrial DNA Against Hypertensive CKD.

Hypertension

September 2025

Department of Cardiology (H.L., L.Z., Z. Lin, Z. Liu, G.H., C.L., F.S., X.G., C.H., Z.C., X.W., Z.W., X.Z., Y.W., Y.X., W.Y., S.W., F.Z., L.T.), Xijing Hospital, Fourth Military Medical University, China.

Background: Hypertension is a significant global health issue that contributes to chronic kidney disease (CKD). Mitochondrial dysfunction in renal tubular epithelial cells (TECs) plays a crucial role in the progression of CKD. However, the involvement of mitochondrial DNA (mtDNA) methylation in hypertensive CKD and its potential as a therapeutic target remains largely unexamined.

View Article and Find Full Text PDF